Weight loss
Supervised weight loss, not a crash diet.
Medication where it’s appropriate, prescribed and monitored by a DHA-licensed doctor.
Eligibility depends on BMI and medical history. Your assessment checks both.
See what medical weight loss could do for you
Peer-reviewed clinical trials demonstrate up to 15% to 22.5% body weight reduction with doctor-monitored GLP-1 and dual GIP/GLP-1 therapies. Drag the slider to project your weight loss trajectory.
Estimated Target Weight: 73.6 kg
Your Projected Clinical Milestones
DHA physician monitoring at each stagePhysiological gastric emptying slows, helping regulate appetite cues and reduce cravings from the first week.
Visceral fat reduction accelerates as your dosage is safely titrated up under DHA physician oversight.
Peak clinical reduction reached with stabilized insulin levels, improved lipid profiles, and cardiovascular health.
*Projections are estimates based on published 68-week and 72-week mean weight reduction data from the SURMOUNT-1 (Tirzepatide) and STEP-1 (Semaglutide) clinical trials. Actual weight loss varies depending on adherence, metabolic profile, and lifestyle factors. All treatments require DHA-licensed physician review and prescription approval.
Medications & options for weight loss
Prices are regulated UAE retail. Not everyone is eligible for these medications, and your doctor may recommend against them.
Find out if you’re eligible.
The assessment checks your BMI and medical history in about two minutes.
A good fit if
- Your BMI is in the range these medicines are licensed for
- Diet and exercise alone have not worked for you
- You are prepared to be monitored over several months
Not suitable if
- You are pregnant, breastfeeding or planning a pregnancy
- You have a personal or family history of medullary thyroid cancer
- You have a history of pancreatitis or an active eating disorder